Article
E3 ligase-inactivation rewires CBL interactome to elicit oncogenesis by hijacking RTK-CBL-CIN85 axis.
Oncogene - 1 Mar 2021
Ahmed Syed Feroj, Buetow Lori, Gabrielsen Mads, Lilla Sergio, Sibbet Gary J, Sumpton David, Zanivan Sara, Hedley Ann, Clark William, Huang Danny T
Abstract excerpt
Casitas B-lineage lymphoma (CBL) is a ubiquitin ligase (E3) that becomes activated upon Tyr371-phosphorylation and targets receptor protein tyrosine kinases for ubiquitin-mediated degradation. Deregulation of CBL and its E3 activity is observed in myeloproliferative neoplasms and other cancers, including breast, colon, and prostate cancer. Here, we explore the oncogenic mechanism of E3-inactive CBL mutants...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
